MiniMed Group, Inc. Common Stock (MMED) Stock Price

MiniMed Group, Inc. Common Stock Price

NYSE·CLOSED
19.11
​
Market closed

Over the last 3 years MiniMed Group, Inc. Common Stock grew revenue by 11.4% annually, reaching 3.10 B USD. For MiniMed Group, Inc. Common Stock, the net margin of -10.7% is down versus -4.3% a few years ago. The consensus 12-month price target for MiniMed Group, Inc. Common Stock is 22.00 USD, about 15.1% above where the stock trades today. Of 18 analysts, 16 rate the stock a buy — an overall Buy consensus.

MiniMed Group, Inc. Common Stock stock price

Access this data via the Eulerpool API

MiniMed Group, Inc. Common Stock business model & stock analysis

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera, or Guardian 4, and wraparound applications and services. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California.

Frequently asked questions about MiniMed Group, Inc. Common Stock

Analysts currently set an average price target of 21.00 USD for the MiniMed Group, Inc. Common Stock stock (median: 22.00 USD), implying +9.9 % versus the latest price. The consensus is based on 18 analyst ratings.

18 analysts currently rate the MiniMed Group, Inc. Common Stock stock: 16 recommend buying, 2 holding and 0 selling.

Converted at the current exchange rate, the MiniMed Group, Inc. Common Stock share trades at 17.05 EUR (19.11 USD).

The revenue of MiniMed Group, Inc. Common Stock is 3.10 B USD. This figure is based on current financial data and reflects the company's business performance.

The profit of MiniMed Group, Inc. Common Stock is -331.00 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of MiniMed Group, Inc. Common Stock is currently -16.22. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the MiniMed Group, Inc. Common Stock stock.

The price-to-sales ratio (P/S) of MiniMed Group, Inc. Common Stock is currently 1.73. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the MiniMed Group, Inc. Common Stock stock.

The Eulerpool Quality Score for MiniMed Group, Inc. Common Stock is 4/10.

The ISIN of MiniMed Group, Inc. Common Stock is US60365F1093. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of MiniMed Group, Inc. Common Stock is MMED. The ticker symbol is used to trade MiniMed Group, Inc. Common Stock shares on the stock exchange.

Fair ValueTerminal
19.49 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
-
Industry
N/A
Number of shares
Employees
Revenue per Employee
387,750.00 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website minimed.com
Currency
USD
Initial public offering
Mar 6, 2026
ISIN
US60365F1093
Market capitalization
5.37 B USDMid Cap
52-Week Range
PEG
-0.44
P/E ratio
P/Ee 2027
28.38
P/Ee 2028
29.41
P/Ee 2029
10.90
P/Ee 2030
8.15
P/Ee 2031
5.97
P/S
P/Se
1.56
EV/EBIT
106.40
P/B Ratio
1.49
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-8.81 %
Last updated Oct 9, 2026, 4:35 AM

MiniMed Group, Inc. Common Stock Peer Group